TW201920662A - 豬小病毒5a、用法及疫苗 - Google Patents

豬小病毒5a、用法及疫苗 Download PDF

Info

Publication number
TW201920662A
TW201920662A TW107130755A TW107130755A TW201920662A TW 201920662 A TW201920662 A TW 201920662A TW 107130755 A TW107130755 A TW 107130755A TW 107130755 A TW107130755 A TW 107130755A TW 201920662 A TW201920662 A TW 201920662A
Authority
TW
Taiwan
Prior art keywords
seq
ppv5a
sequence
polypeptide
infection
Prior art date
Application number
TW107130755A
Other languages
English (en)
Chinese (zh)
Inventor
V 艾爾亞倫
M 墨非 喬登黛安娜
雷 派特森艾比
B 魯夫麥可
馬丁 瓦格恩艾瑞克
吉伯特 維多利亞喬許
安 維薩克卡利
Original Assignee
美商百靈佳殷格翰家畜藥品公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=50931160&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=TW201920662(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 美商百靈佳殷格翰家畜藥品公司 filed Critical 美商百靈佳殷格翰家畜藥品公司
Publication of TW201920662A publication Critical patent/TW201920662A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/23—Parvoviridae, e.g. feline panleukopenia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14021—Viruses as such, e.g. new isolates, mutants or their genomic sequences
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/14011—Parvoviridae
    • C12N2750/14034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
TW107130755A 2012-12-17 2013-12-16 豬小病毒5a、用法及疫苗 TW201920662A (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261738110P 2012-12-17 2012-12-17
US61/738,110 2012-12-17
US13/796,621 2013-03-12
US13/796,621 US20140170180A1 (en) 2012-12-17 2013-03-12 Porcine parvovirus 5a, methods of use and vaccine

Publications (1)

Publication Number Publication Date
TW201920662A true TW201920662A (zh) 2019-06-01

Family

ID=50931160

Family Applications (2)

Application Number Title Priority Date Filing Date
TW107130755A TW201920662A (zh) 2012-12-17 2013-12-16 豬小病毒5a、用法及疫苗
TW102146453A TWI656213B (zh) 2012-12-17 2013-12-16 豬小病毒５ａ、用法及疫苗

Family Applications After (1)

Application Number Title Priority Date Filing Date
TW102146453A TWI656213B (zh) 2012-12-17 2013-12-16 豬小病毒５ａ、用法及疫苗

Country Status (16)

Country Link
US (2) US20140170180A1 (es)
EP (1) EP2931741B1 (es)
AR (1) AR094725A1 (es)
AU (1) AU2014203571B2 (es)
CA (1) CA2894708A1 (es)
CL (1) CL2015001689A1 (es)
CO (1) CO7461133A2 (es)
DK (1) DK2931741T3 (es)
EA (1) EA031278B1 (es)
ES (1) ES2689515T3 (es)
MX (1) MX2015007723A (es)
PH (1) PH12015501378A1 (es)
SG (1) SG11201504805PA (es)
TW (2) TW201920662A (es)
UA (1) UA117467C2 (es)
WO (1) WO2014099669A1 (es)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
US20140234354A1 (en) 2013-02-15 2014-08-21 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5b, methods of use and vaccine
KR102392649B1 (ko) * 2014-04-17 2022-04-28 인터벳 인터내셔널 비.브이. 돼지 파르보바이러스
WO2016210097A1 (en) * 2015-06-23 2016-12-29 The Trustees Of Columbia University In The City Of New York Novel equine parvovirus and uses thereof
MX2019005136A (es) 2016-11-03 2019-06-20 Boehringer Ingelheim Vetmedica Gmbh Vacuna contra el parvovirus porcino y el virus del sindrome respiratorio reproductivo porcino y metodos de produccion de esta.
BR112019009133A2 (pt) 2016-11-03 2019-07-16 Boehringer Ingelheim Vetmedica Gmbh vacina contra o parvovírus suíno
KR102243368B1 (ko) * 2019-04-17 2021-04-23 대한민국 돼지파보바이러스에 특이적인 단일클론항체 및 이의 용도
CN111454969B (zh) * 2019-09-02 2022-08-26 西北农林科技大学 带有双标签猪细小病毒全长感染性克隆制备方法及应用

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2909462A (en) 1955-12-08 1959-10-20 Bristol Myers Co Acrylic acid polymer laxative compositions
EP0117767A1 (en) 1983-01-07 1984-09-05 Mgi Pharma, Inc. Production of parvovirus subunit vaccines
CA1247080A (en) 1983-03-08 1988-12-20 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
US4567043A (en) 1983-06-15 1986-01-28 American Home Products Corporation (Del.) Canine corona virus vaccine
US4567042A (en) 1983-06-15 1986-01-28 American Home Products Corporation Inactivated canine coronavirus vaccine
FR2751227B1 (fr) 1996-07-19 1998-11-27 Rhone Merieux Formule de vaccin polynucleotidique contre les pathologies canines, notamment les pathologies respiratoires et digestives
AU4645697A (en) * 1996-09-11 1998-04-02 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Aav4 vector and uses thereof
US20030049647A1 (en) * 2001-02-22 2003-03-13 Bassil Dahiyat Use of nucleic acid libraries to create toxicological profiles
US10336797B2 (en) 2009-11-23 2019-07-02 Research Development Foundation Recombinant filaggrin polypeptides for cell importation
US20140170180A1 (en) 2012-12-17 2014-06-19 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5a, methods of use and vaccine
US20140234354A1 (en) 2013-02-15 2014-08-21 Boehringer Ingelheim Vetmedica, Inc. Porcine parvovirus 5b, methods of use and vaccine
KR102392649B1 (ko) 2014-04-17 2022-04-28 인터벳 인터내셔널 비.브이. 돼지 파르보바이러스
US10954491B2 (en) 2014-12-19 2021-03-23 Intervet Inc. Pestivirus
UA124140C2 (uk) 2015-08-31 2021-07-28 Бьорінгер Інгельхайм Ветмедіка Гмбх Пестивірусна вакцина проти вродженого тремору поросят
BR112019009133A2 (pt) 2016-11-03 2019-07-16 Boehringer Ingelheim Vetmedica Gmbh vacina contra o parvovírus suíno

Also Published As

Publication number Publication date
AU2014203571B2 (en) 2017-09-28
PH12015501378B1 (en) 2015-09-02
ES2689515T3 (es) 2018-11-14
EP2931741A1 (en) 2015-10-21
AR094725A1 (es) 2015-08-26
EA201500643A1 (ru) 2015-12-30
DK2931741T3 (en) 2018-10-22
CA2894708A1 (en) 2014-06-26
AU2014203571A1 (en) 2015-06-11
US20150246113A1 (en) 2015-09-03
WO2014099669A1 (en) 2014-06-26
CO7461133A2 (es) 2015-11-30
MX2015007723A (es) 2015-09-23
UA117467C2 (uk) 2018-08-10
TWI656213B (zh) 2019-04-11
US9833507B2 (en) 2017-12-05
SG11201504805PA (en) 2015-07-30
EA031278B1 (ru) 2018-12-28
PH12015501378A1 (en) 2015-09-02
TW201437369A (zh) 2014-10-01
CL2015001689A1 (es) 2016-09-09
US20140170180A1 (en) 2014-06-19
EP2931741B1 (en) 2018-07-25

Similar Documents

Publication Publication Date Title
JP7445375B2 (ja) ブタサーコウイルス３型免疫原性組成物、その製造方法、およびその使用方法
TWI656213B (zh) 豬小病毒５ａ、用法及疫苗
TWI466682B (zh) 以豬第二型環狀病毒（ｐｃｖ２）抗原治療豬
US11179457B2 (en) Senecavirus a immunogenic compositions and methods thereof
JP2017192398A (ja) ブタパルボウイルス５ｂ型、使用方法およびワクチン
US11896659B2 (en) Porcine Circovirus Type 3 (PCV3) vaccines, and production and uses thereof
JP6072935B2 (ja) ブタパルボウイルス５ａ、使用方法およびワクチン
CN105263953B (zh) 猪细小病毒5a、使用方法及疫苗
WO2019092027A1 (en) Sapelovirus immunogenic compositions and uses thereof
RU2803427C1 (ru) Иммуногенные композиции для иммунизации свиней против цирковируса типа 3 и способы их получения и применения